Curis (CRIS) to Unveil Pre-Clinical Data on IRAK4 Kinase Inhibitor CA-4948 at AACR Meeting 4/1-4/5
Tweet Send to a Friend
Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE